TY - JOUR
T1 - Bronchopulmonary dysplasia
T2 - Impact of surfactant replacement therapy
AU - McColley, S. A.
PY - 1998
Y1 - 1998
N2 - Bronchopulmonary dysplasia is a major contributor to the morbidity and mortality of infants born prematurely. Surfactant replacement therapy has had a significant impact on the death rate from respiratory distress syndrome, yet the impact on bronchopulmonary dysplasia is minimal. Despite these findings, the overall incidence and severity of bronchopulmonary dysplasia are likely to decline over time as neonatal care continues to advance.
AB - Bronchopulmonary dysplasia is a major contributor to the morbidity and mortality of infants born prematurely. Surfactant replacement therapy has had a significant impact on the death rate from respiratory distress syndrome, yet the impact on bronchopulmonary dysplasia is minimal. Despite these findings, the overall incidence and severity of bronchopulmonary dysplasia are likely to decline over time as neonatal care continues to advance.
UR - http://www.scopus.com/inward/record.url?scp=0031841633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031841633&partnerID=8YFLogxK
U2 - 10.1016/S0031-3955(05)70028-6
DO - 10.1016/S0031-3955(05)70028-6
M3 - Article
C2 - 9653437
AN - SCOPUS:0031841633
SN - 0031-3955
VL - 45
SP - 573
EP - 586
JO - Pediatric Clinics of North America
JF - Pediatric Clinics of North America
IS - 3
ER -